·
2 MIN READ

Feb. 14, 2020: State Advocacy Update

AMA opposes the OptumRx EPCS home delivery requirement grace period, which may conflict with state laws.

Advocacy Update
Health care professional using a tablet
·
3 MIN READ

New Jersey rejects bill to weaken doctors’ role as care team leaders

The legislation would have allowed advanced practice registered nurses to prescribe without any physician oversight. The Medical Society of New Jersey advocated against the bill with help from the AMA Scope of Practice Partnership.

Scope of Practice
Person driving while holding smartphone
·
3 MIN READ

Distracted driving: Most states aren’t cracking down on deadly practice

Eight Americans are killed every day in a car crash involving a distracted driver, and more than 1,000 are injured daily in such accidents, says the National Highway Traffic Safety Administration.

Public Health
·
3 MIN READ

Saving time and lives by increased access to MAT in Pennsylvania

John Gallagher, MD, asked policymakers the hard questions about why barriers to effective treatment were allowed to persist.

Prior Authorization
·
5 MIN READ

Dec. 20, 2019: State Advocacy Update

Walmart EPCS delay, new tool from AMA, APA and ASAM and more in the AMA's latest state and local advocacy efforts.

Advocacy Update
·
3 MIN READ

Dec. 6, 2019: State Advocacy Update

AMA urges Walmart, OptumRx to delay EPCS requirements and Colorado focuses on evidence-based approaches to end opioid epidemic in the latest AMA state advocacy news.

Advocacy Update
13 MIN READ

CVS-Aetna merger

The AMA aims to protect patients and physicians by actively opposing anticompetitive health insurer mergers.

Access to Care
·
3 MIN READ

July 25, 2019: Advocacy spotlight on Scrutiny of CVS-Aetna deal shows AMA's powerful impact

The scrutiny of CVS-Aetna deal shows AMA's powerful impact on the health care system. Learn more.

Advocacy Update
·
4 MIN READ

March 7, 2019: State Advocacy Update

State medical societies work to remove prior authorization for MAT, Massachusetts Insurance Commissioner's naloxone bulletin and more in AMA's state advocacy efforts.

Advocacy Update